Human fetal osteoclasts fail to express macrophage antigens.

PubWeight™: 0.94‹?›

🔗 View Article (PMC 2041025)

Published in Br J Exp Pathol on February 01, 1985

Authors

M A Horton, D Lewis, K McNulty, J A Pringle, T J Chambers

Articles by these authors

Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest (1999) 7.69

Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med (2011) 4.98

Results of Operations at the Johns Hopkins Hospital for Cancer of the Breast: Performed at the Johns Hopkins Hospital from 1889 to 1931. Ann Surg (1932) 4.54

Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation. New Biol (1989) 4.46

Tumors of the breast related to the oestrin hormone. Am J Cancer (1934) 3.51

GYNECOMASTIA, VIRGINAL HYPERTROPHY AND FIBROADENOMAS OF THE BREAST. Ann Surg (1934) 2.83

SUBCUTANEOUS INJURIES OF THE ABDOMEN. Ann Surg (1933) 2.77

Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med (1997) 2.77

TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med (1998) 2.68

Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol (1987) 2.59

Cleavage at a novel site in the NS4A region by the yellow fever virus NS2B-3 proteinase is a prerequisite for processing at the downstream 4A/4B signalase site. J Virol (1993) 2.56

Broadly reactive reverse transcriptase polymerase chain reaction for the diagnosis of SRSV-associated gastroenteritis. J Med Virol (1995) 2.53

Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study. Neurology (1997) 2.43

Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens. Cancer Res (1985) 2.42

A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. J Clin Invest (1997) 2.37

Toxic amino acids: their action as antimetabolites. Adv Enzymol Relat Areas Mol Biol (1967) 2.35

Resorption of bone by isolated rabbit osteoclasts. J Cell Sci (1984) 2.33

Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. J Immunol (1997) 2.30

Nuclear localization of type I parathyroid hormone/parathyroid hormone-related protein receptors in deer antler osteoclasts: evidence for parathyroid hormone-related protein and receptor activator of NF-kappaB-dependent effects on osteoclast formation in regenerating mammalian bone. J Bone Miner Res (2002) 2.12

Colitis causes bone loss in rats through suppression of bone formation. Gastroenterology (1996) 2.09

Rate and pattern of epithelial cell proliferation in ulcerative colitis. Gut (1981) 2.08

Calcitonin alters behaviour of isolated osteoclasts. J Pathol (1982) 2.06

Multinucleate giant cells. J Pathol (1978) 2.04

Spatial and temporal variation in abundance of Anopheles (Diptera:Culicidae) in a malaria endemic area in Papua New Guinea. J Med Entomol (1997) 2.04

Colonic adenomas--a colonoscopy survey. Gut (1979) 2.01

Parental confidence in measles, mumps and rubella vaccine: evidence from vaccine coverage and attitudinal surveys. Br J Gen Pract (2002) 2.00

Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. J Exp Med (1999) 2.00

Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat Genet (2000) 1.96

Norwalk-like viruses: demonstration of genomic diversity by polymerase chain reaction. J Clin Microbiol (1993) 1.96

Trafficking of matrix collagens through bone-resorbing osteoclasts. Science (1997) 1.93

Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. J Exp Med (1997) 1.89

Mutagenesis of the N-linked glycosylation sites of the yellow fever virus NS1 protein: effects on virus replication and mouse neurovirulence. Virology (1996) 1.87

Molecular detection and epidemiology of Sapporo-like viruses. J Clin Microbiol (2000) 1.86

Use of CHROMagar Candida medium for isolation of yeasts from dental samples. J Clin Microbiol (1995) 1.83

Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates. J Virol (2000) 1.79

Single integrin molecule adhesion forces in intact cells measured by atomic force microscopy. Biochem Biophys Res Commun (1999) 1.74

Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn (2002) 1.74

TUMORS OF PERIPHERAL NERVES. Ann Surg (1930) 1.73

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates. Vaccine (1999) 1.70

Mutagenesis of conserved residues at the yellow fever virus 3/4A and 4B/5 dibasic cleavage sites: effects on cleavage efficiency and polyprotein processing. Virology (1993) 1.70

Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). J Am Coll Cardiol (2001) 1.70

GFAP mutations, age at onset, and clinical subtypes in Alexander disease. Neurology (2011) 1.69

Distinct epidemiological patterns of Norwalk-like virus infection. J Med Virol (2000) 1.66

4-ethylsulphonylnaphthalene-1-sulphonamide: a new chemical for the study of bladder cancer in the mouse. Biochem Pharmacol (1967) 1.65

Norwalk agent and other small-round structured viruses in the U.K. J Infect (1991) 1.64

Mutagenesis of the yellow fever virus NS2A/2B cleavage site: effects on proteolytic processing, viral replication, and evidence for alternative processing of the NS2A protein. Virology (1994) 1.63

Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med (1993) 1.63

Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis. Virology (1999) 1.56

GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons. Am J Psychiatry (2001) 1.55

Occult neonatal seizures. Epilepsia (1988) 1.55

The granuloma in Crohn's disease. Gut (1979) 1.54

Molecular findings in symptomatic and pre-symptomatic Alexander disease patients. Neurology (2002) 1.54

Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology (1986) 1.52

Hemodynamics and anatomy of elastase-induced rabbit aneurysm models: similarity to human cerebral aneurysms? AJNR Am J Neuroradiol (2011) 1.51

Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts. J Exp Med (1986) 1.50

Apoptosis induced by inhibition of intercellular contact. J Cell Biol (1994) 1.49

Mycobacterial meningomyelitis associated with human immunodeficiency virus infection. Arch Neurol (1988) 1.49

The pathobiology of the osteoclast. J Clin Pathol (1985) 1.48

A role for TGFbeta(1) in osteoclast differentiation and survival. J Cell Sci (2000) 1.47

Performance of the applied biosystems ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for sequence-based analysis of HIV-1 in pediatric plasma samples. J Clin Microbiol (2001) 1.47

Calcitonin receptors as markers for osteoclastic differentiation: correlation between generation of bone-resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures. Endocrinology (1989) 1.44

Abdominal and Cardiac Evaluation with Sonography in Shock (ACES): an approach by emergency physicians for the use of ultrasound in patients with undifferentiated hypotension. Emerg Med J (2009) 1.44

Macrophage colony stimulating factor (M-CSF) is essential for osteoclast formation in vitro. Biochem Biophys Res Commun (1991) 1.43

Failure of cells of the mononuclear phagocyte series to resorb bone. Calcif Tissue Int (1984) 1.43

Workload and stress in consultant medical microbiologists and virologists: a questionnaire survey. J Clin Pathol (2002) 1.42

Gallium inhibits bone resorption by a direct effect on osteoclasts. Bone Miner (1990) 1.42

PERIPHERAL NERVE INJURIES ASSOCIATED WITH FRACTURES. Ann Surg (1922) 1.42

Why isolate theatre suites? Lancet (1991) 1.39

Recurrent tetanus. Lancet (2004) 1.39

The cellular basis of bone resorption. Clin Orthop Relat Res (1980) 1.38

Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption. Endocrinology (1986) 1.37

The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. Endocrinology (1985) 1.35

The multinucleate cells in giant cell granulomas of the jaw are osteoclasts. Cancer (1988) 1.34

Intimin-specific immune responses prevent bacterial colonization by the attaching-effacing pathogen Citrobacter rodentium. Infect Immun (2001) 1.34

Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J Virol (2001) 1.32

Predicting hypoxia in children with acute lower respiratory infection: a study in the highlands of Papua New Guinea. J Trop Pediatr (1995) 1.32

Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPD. Chest (1999) 1.31

Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New Guinea. Am J Trop Med Hyg (1994) 1.30

Genomic diversity of small round structured viruses in the United Kingdom. J Med Virol (1994) 1.29

The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes. J Biol Chem (1987) 1.29

Cell surface characterization of the human osteoclast: phenotypic relationship to other bone marrow-derived cell types. J Pathol (1984) 1.28

Workshop on schizophrenia. Proc Natl Acad Sci U S A (1997) 1.28

Viral measurement by polymerase chain reaction-based assays in human immunodeficiency virus-infected infants. J Pediatr (1995) 1.27

Induction of NO and prostaglandin E2 in osteoblasts by wall-shear stress but not mechanical strain. Am J Physiol (1997) 1.26

Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone. Bone Miner (1989) 1.23

Gonadal steroids: effects on excitability of hippocampal pyramidal cells. Science (1980) 1.23

Beta 1 integrins and osteoclast function: involvement in collagen recognition and bone resorption. Bone (1996) 1.23

The effects of calcium regulating hormones on bone resorption by isolated human osteoclastoma cells. J Pathol (1985) 1.23

Identification of a novel phosphonocarboxylate inhibitor of Rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages. J Biol Chem (2001) 1.22

Sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA) gene silencing and remodeling of the Ca2+ signaling mechanism in cardiac myocytes. Proc Natl Acad Sci U S A (2004) 1.21